| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002826-200009000-00002 |
| P698 | PubMed publication ID | 11154091 |
| P2093 | author name string | Bressman SB | |
| P433 | issue | 5 | |
| P304 | page(s) | 239-251 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Clinical Neuropharmacology | Q15753218 |
| P1476 | title | Dystonia update. | |
| P478 | volume | 23 |
| Q33244571 | A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force |
| Q37792237 | Assessment and Treatment of Movement Disorders in Children with Cerebral Palsy |
| Q35208420 | Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments |
| Q48348725 | Bilateral subthalamic nucleus stimulation for generalized dystonia after bilateral pallidotomy |
| Q37586904 | Botulinum toxin type A in the treatment of patients with cervical dystonia |
| Q33756951 | Convergent evidence for abnormal striatal synaptic plasticity in dystonia |
| Q51509072 | Deep Brain Stimulation for Dystonia. |
| Q34202236 | Diagnosis of dystonic syndromes--a new eight-question approach |
| Q31069022 | Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options |
| Q35603764 | Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management |
| Q39143529 | How Many Dystonias? Clinical Evidence |
| Q35684473 | Microstructural white matter changes in primary torsion dystonia |
| Q34501600 | Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features |
| Q24292359 | Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins |
| Q35292279 | Movement disorders in children: definitions, classifications, and grading systems |
| Q35105747 | New Perspectives on Dystonia |
| Q38537633 | Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment |
| Q34596357 | Pathophysiology of dystonia: a neuronal model |
| Q35574920 | Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy |
| Q35660951 | Primary blepharospasm: diagnosis and management |
| Q30559524 | Primary dystonia misinterpreted as Parkinson disease: Video case presentation and practical clues |
| Q36839427 | The Frequency of DYT1 (GAG Deletion) Mutation in Primary Dystonia Patients from Iran |
| Q48378126 | TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion |
| Q45143385 | Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report |
| Q50283150 | Usefulness and limitations of polymygraphic recordings in dystonia |
Search more.